# Easy Diabetes Treatment Study 1

Study · id `cardio:ct-nct03258268` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03258268](<https://clinicaltrials.gov/study/NCT03258268>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03258268

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 311 participants.

## Technical summary

Registry record NCT03258268. Randomized; single masking; primary purpose treatment. Start 2017-08-07 (actual); primary completion 2019-12-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 311 participants (enrolled count; ClinicalTrials.gov record NCT03258268, source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)
- Started: 2017-08-07 (actual) (ClinicalTrials.gov record NCT03258268, source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)
- Primary completion: 2019-12-12 (actual) (ClinicalTrials.gov record NCT03258268, source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)
- Completion: 2019-12-19 (actual) (ClinicalTrials.gov record NCT03258268, source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT03258268, source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03258268-2020-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Easy Diabetes Treatment Study 1
- Acronym: EASY-1
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Standard of Care with EASY DSS
- Intervention (Other): Standard of Care without EASY DSS
- Lead sponsor: Läkarexpressen AB
- Lead sponsor class: INDUSTRY
- Collaborator: Region Skane
- Collaborator class: OTHER
- Collaborator: Lund University
- Collaborator class: OTHER
- Collaborator: Region Halland
- Collaborator class: OTHER
- Collaborator: Västra Götalandsregionen
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Region Skane (`cardio:org-region-skane`)
- Registry lists this organization as a collaborator: Lund University (`cardio:org-lund-university`)
- Registry lists this organization as a collaborator: Region Halland (`cardio:org-region-halland`)

## Provenance

Content hash: 2caa1d127479ee0763698b1cb66ad99deb216ad1ee46cec46a540ae07e4fa8a6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
